AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-094490 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
327
Total Value
$346.62
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Common Stock | โ | Mar 3, 2026 | Sale | 327 | $1.06 | $346.62 | 66,848 | Direct | โ | View Details |